COVID-19 treatment, Keytruda boost drugmaker Merck in Q1

Apr 28, 2022, 3:38 AM | Updated: 8:12 am

Merck soared past first-quarter expectations, helped by sales of its long-standing blockbuster cancer drug Keytruda and a new COVID-19 treatment that also topped forecasts.

The drugmaker raised its 2022 forecast Thursday after its coronavirus treatment molnupiravir brought in almost $3.2 billion in sales in the quarter.

Analysts were expecting $2.54 billion from the drug, which debuted late last year under the brand name Lagevrio.

Merck has said it expects the capsules to bring in sales of $5 billion or more this year. But analysts are starting to wonder whether all the treatment courses Merck makes will get used.

One analyst said on a Thursday call with company leaders that some data shows the treatment Paxlovid from rival Pfizer is being used much more frequently. The analyst noted that the U.S. has contracted to have 3.1 million courses of Lagevrio delivered and asked if there was a recourse for the government to return unused portions.

Chief Financial Officer Caroline Litchfield said the company expects the roughly 6.4 million treatment courses that it has delivered so far globally to be used over time, and the drugmaker remains “confident in our financials.”

She said data they have access to suggests that 500,000 people have used Lagevrio so far globally, and use has been particularly strong outside the United States.

Governments have been using and stockpiling both Lagevrio, which is also made by Ridgeback Biotherapeutics, and Paxlovid, which was shown to be more effective in clinical research, after the omicron surge of the virus filled hospitals earlier this year.

The treatments have been seen as a breakthrough in the fight to control the ongoing pandemic because they are effective and are easier for patients to use than other drugs that require injections or IV infusions.

The drugs are being used to treat patients most at risk of winding up in a hospital from the virus.

Both Lagevrio and Paxlovid must be used soon after COVID-19 symptoms appear, and U.S. President Joe Biden is pushing to expand their availability.

The treatments are free to patients in the U.S.

Not counting Lagevrio, Merck said its pharmaceutical revenue still grew 18% in the first quarter. Sales of Keytruda climbed 23% to $4.81 billion.

Overall, Merck’s profit climbed 36% to $4.31 billion.

Adjusted earnings, which exclude one-time items, totaled $2.14 per share. Total sales jumped 50% to $15.9 billion.

Analysts expected, on average, earnings of $1.83 per share on about $14.55 billion in revenue in the quarter.

The company also said Thursday it was raising and narrowing its forecast for the year. Merck now expects adjusted earnings to range between $7.24 and $7.36 per share after forecasting $7.12 to $7.27 per share in February.

Analysts expect earnings of $7.28 per share, according to FactSet.

Shares of Merck & Co. Inc., based in Kenilworth, New Jersey, climbed more than 3% to $87.38 late Thursday morning. The Dow Jones Industrial Average, of which Merck is a component, rose slightly.


Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Lead water pipes pulled from underneath the street are seen in Newark, N.J., Oct. 21, 2021. (AP Pho...

Associated Press

Biden to require cities to replace harmful lead pipes within 10 years

The Biden administration has previously said it wants all of the nation's roughly 9 million lead pipes to be removed, and rapidly.

21 hours ago

Facebook's Meta logo sign is seen at the company headquarters in Menlo Park, Calif., on, Oct. 28, 2...

Associated Press

Meta shuts down thousands of fake Facebook accounts that were primed to polarize voters ahead of 2024

Meta said it removed 4789 Facebook accounts in China that targeted the United States before next year’s election.

23 hours ago

A demonstrator in Tel Aviv holds a sign calling for a cease-fire in the Hamas-Israel war on Nov. 21...

Associated Press

Hamas releases a third group of hostages as part of truce, and says it will seek to extend the deal

The fragile cease-fire between Israel and Hamas was back on track Sunday as the first American was released under a four-day truce.

6 days ago

Men look over the site of a deadly explosion at Al-Ahli Hospital in Gaza City, Wednesday, Oct. 18, ...

Associated Press

New AP analysis of last month’s deadly Gaza hospital explosion rules out widely cited video

The Associated Press is publishing an updated visual analysis of the deadly Oct. 17 explosion at Gaza's Al-Ahli Hospital.

9 days ago

Peggy Simpson holds a photograph of law enforcement carrying Lee Harvey Oswald's gun through a hall...

Associated Press

JFK assassination remembered 60 years later by surviving witnesses to history, including AP reporter

Peggy Simpson is among the last surviving witnesses who are sharing their stories as the nation marks the 60th anniversary.

9 days ago

Israeli Prime Minister Benjamin Netanyahu, chairs the weekly cabinet meeting in Jerusalem, Sunday, ...

Associated Press

Israeli Cabinet approves cease-fire with Hamas; deal includes release of 50 hostages

Israel’s Cabinet on Wednesday approved a cease-fire deal with the Hamas militant group that would bring a temporary halt to a devastating war.

10 days ago

Sponsored Articles

Follow @KTAR923...

Valley residents should be mindful of plumbing ahead of holidays

With Halloween in the rear-view and more holidays coming up, Day & Night recommends that Valley residents prepare accordingly.

Follow @KTAR923...

The 2023 Diamondbacks are a good example to count on the underdog

The Arizona Diamondbacks made the World Series as a surprise. That they made the playoffs at all, got past the Milwaukee Brewers in the NL Wild Card round, swept the Los Angeles Dodgers in the NLDS and won two road games in Philadelphia to close out a full seven-game NLCS went against every expectation. Now, […]



Key dates for Arizona sports fans to look forward to this fall

Fall brings new beginnings in different ways for Arizona’s professional sports teams like the Cardinals and Coyotes.

COVID-19 treatment, Keytruda boost drugmaker Merck in Q1